|
Volumn 24, Issue 6 SUPPL. 19, 1997, Pages
|
Paclitaxel, cisplatin, and 5-fluorouracil in patients with advanced or recurrent squamous cell carcinoma of the head and neck: A preliminary report
a a a a |
Author keywords
[No Author keywords available]
|
Indexed keywords
CISPLATIN;
FLUOROURACIL;
PACLITAXEL;
ADULT;
ADVANCED CANCER;
AGED;
ANEMIA;
ARTICLE;
CANCER COMBINATION CHEMOTHERAPY;
CANCER SURVIVAL;
CLINICAL ARTICLE;
CLINICAL TRIAL;
DOSE RESPONSE;
FEMALE;
GASTROINTESTINAL SYMPTOM;
HEAD AND NECK CANCER;
HUMAN;
HUMAN CELL;
HUMAN TISSUE;
MALE;
MUCOSA INFLAMMATION;
NEUTROPENIA;
PHASE 1 CLINICAL TRIAL;
PHASE 2 CLINICAL TRIAL;
PRIORITY JOURNAL;
RECURRENT CANCER;
SQUAMOUS CELL CARCINOMA;
THROMBOCYTOPENIA;
AGED;
ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS;
CARCINOMA, SQUAMOUS CELL;
CISPLATIN;
DRUG ADMINISTRATION SCHEDULE;
FEMALE;
FLUOROURACIL;
HEAD AND NECK NEOPLASMS;
HUMANS;
MALE;
MIDDLE AGED;
NEOPLASM RECURRENCE, LOCAL;
PACLITAXEL;
PILOT PROJECTS;
|
EID: 0031475069
PISSN: 00937754
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
Times cited : (11)
|
References (4)
|